Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chisato M Yamazaki

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Macromolecular Rapid Communications|March 6, 2012
Surface-modifiable free-floating films formed by multiway connection of collagen-like triple-helical peptidesShunsuke Matsui, Chisato M Yamazaki, Takaki Koide
Biopolymers|October 11, 2008
Artificial collagen gels via self-assembly of de novo designed peptidesChisato M Yamazaki, Shinichi Asada, Kouki Kitagawa, et al.
The Journal of Biological Chemistry|June 10, 2011
Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin/heparan sulfate proteoglycansAtsushi Sekiya, Hitomi Okano-Kosugi, Chisato M Yamazaki, et al.
Nature Reviews. Clinical Oncology|January 9, 2024
Exploring the next generation of antibody-drug conjugatesKyoji Tsuchikama, Yasuaki Anami, Summer Y Y Ha, et al.
Plos One|September 2, 2025
A cytotoxic peptide-drug conjugate for tumor-specific delivery of co-injected moleculesNorio Miyamura, Chisato M Yamazaki, Yasuaki Anami, et al.
Biopolymers|March 16, 2013
Potential of collagen-like triple helical peptides as drug carriers: Their in vivo distribution, metabolism, and excretion profiles in rodentsHiroyuki Yasui, Chisato M Yamazaki, Hiroshi Nose, et al.
RSC Advances|April 15, 2022
Homogeneous antibody-angiopep 2 conjugates for effective brain targetingYasuaki Anami, Wei Xiong, Aiko Yamaguchi, et al.
Nature Communications|June 30, 2018
Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in miceYasuaki Anami, Chisato M Yamazaki, Wei Xiong, et al.
Biomaterials|October 27, 2009
A collagen-mimetic triple helical supramolecule that evokes integrin-dependent cell responsesChisato M Yamazaki, Yuichi Kadoya, Kentaro Hozumi, et al.
Molecular Cancer Therapeutics|September 4, 2020
LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid LeukemiaYasuaki Anami, Mi Deng, Xun Gui, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Macromolecular Rapid Communications|March 6, 2012
Surface-modifiable free-floating films formed by multiway connection of collagen-like triple-helical peptidesShunsuke Matsui, Chisato M Yamazaki, Takaki Koide
Biopolymers|October 11, 2008
Artificial collagen gels via self-assembly of de novo designed peptidesChisato M Yamazaki, Shinichi Asada, Kouki Kitagawa, et al.
The Journal of Biological Chemistry|June 10, 2011
Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin/heparan sulfate proteoglycansAtsushi Sekiya, Hitomi Okano-Kosugi, Chisato M Yamazaki, et al.
Nature Reviews. Clinical Oncology|January 9, 2024
Exploring the next generation of antibody-drug conjugatesKyoji Tsuchikama, Yasuaki Anami, Summer Y Y Ha, et al.
Plos One|September 2, 2025
A cytotoxic peptide-drug conjugate for tumor-specific delivery of co-injected moleculesNorio Miyamura, Chisato M Yamazaki, Yasuaki Anami, et al.
Biopolymers|March 16, 2013
Potential of collagen-like triple helical peptides as drug carriers: Their in vivo distribution, metabolism, and excretion profiles in rodentsHiroyuki Yasui, Chisato M Yamazaki, Hiroshi Nose, et al.
RSC Advances|April 15, 2022
Homogeneous antibody-angiopep 2 conjugates for effective brain targetingYasuaki Anami, Wei Xiong, Aiko Yamaguchi, et al.
Nature Communications|June 30, 2018
Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in miceYasuaki Anami, Chisato M Yamazaki, Wei Xiong, et al.
Biomaterials|October 27, 2009
A collagen-mimetic triple helical supramolecule that evokes integrin-dependent cell responsesChisato M Yamazaki, Yuichi Kadoya, Kentaro Hozumi, et al.
Molecular Cancer Therapeutics|September 4, 2020
LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid LeukemiaYasuaki Anami, Mi Deng, Xun Gui, et al.
Pageof 2